451 Results
Sort By:
Published on June 21, 2023
Sporting an all-star team of scientific founders that includes Charles Chiu, MD, PhD, Joe DeRisi, PhD, Michael Wilson, MD, Pardis Sabeti, MD, DPhil, and Matthew Meyerson, MD, PhD, Delve Bio announced its launch via a $35 million Series A financing that will help commercialize its metagenomic sequencing platform for infectious…
Published on November 2, 2022
Arcturus Therapeutics, which has proprietary mRNA technology, has announced a strategic collaboration with CSL Seqirus, a global leader in the development, manufacture, and commercialization of vaccines for several infectious diseases. CSL Seqirus’ vaccine portfolio includes the world’s second largest influenza vaccine franchise. Seqirus is part of CSL Limited. Arcturus will…
Published on June 29, 2022
View eBook Prior to the pandemic, most folks outside of the industry wouldn’t have been familiar with the term reagent. The word, much like PCR, has now become part of common parlance. For those of us immersed in the world of diagnostic assays we know only too well how important…
Published on May 4, 2022
An insect odorant receptor will be added to Cardea Bio’s Biosignal Processing Unit (BPU) to detect infectious diseases like SARS-CoV-2 in the air in a collaboration with the Bill and Melinda Gates Foundation. The San Diego health tech company was founded in 2013 and has specialized in making and refining…
Published on August 25, 2021
Back in 2015, when Bill Gates famously declared we were “not ready for the next outbreak,” few people could have predicted how true his words would be and what kind of global impact that next outbreak would have. But the COVID-19 pandemic has not only altered most of our lives…
Published on August 28, 2020
The National Institutes of Health (NIH) via the National Institute of Allergy and Infectious Diseases (NIAID), announce that is has awarded grants totaling approximately $17 million to 11 research centers to establish the Centers for Research in Emerging Infectious Diseases (CREID). CREID will build a network of multidisciplinary researchers around…
Published on September 6, 2019
OpGen and Curetis said they will merge into a transatlantic diagnostics developer focused on molecular diagnostics and bioinformatics, with a pipeline of diagnostics specializing in infectious diseases and antimicrobial resistance (AMR). The combined company will market a commercial-stage diagnostics portfolio of CE-IVD-marked and FDA-cleared products and platforms, plus proprietary NGS-based…
Published on September 3, 2019
In recent years we’ve seen the power of analyzing cell-free DNA to diagnose and track the progression of cancer. Yet, using this technology as a diagnostic tool for infectious diseases required scientists to overcome numerous hurdles. For instance, a common problem in diagnosing infectious disease is that the presence of…
Published on January 28, 2019
Infectious disease diagnostics company Day Zero Diagnostics announced it has closed a $8.6 million Series A financing round led by healthcare-focused venture capital firm Triventures with additional funding from Sands Capital Ventures and Golden Seeds. Day Zero, founded in 2016 by researchers from Harvard and Mass General Hospital, is developing…
Published on November 6, 2018
BGI Group and the Fred Hutchinson Cancer Research Center have signed a memorandum of understanding committing them to explore cooperative projects in genomics. The memorandum “provides a framework to support a range of mutually agreed research areas including cancer genomics, immunology and infectious disease research,” BGI said in a statement…
Published on August 24, 2018
Bruker said today it has agreed to acquire a majority stake in Hain Lifescience for an undisclosed price, in a deal that aligns with the buyer’s goals of expanding its presence in the infectious disease and molecular diagnostics markets. Based in Nehren, Germany, Hain is a developer of infectious disease…
Published on May 11, 2018
Talis Biomedical has won up to $8.6 million from the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) toward developing a pair of rapid molecular diagnostic tests for infectious diseases. Talis said its funding from CARB-X will fund development of a rapid CLIA-waived molecular diagnostic test designed to detect chlamydia and…
Published on January 26, 2018
PlexBio said it plans to expand its 16-month-old collaboration with Denka by adding a new program in which the companies will codevelop a molecular diagnostic system designed to detect infectious disease. The companies envision a high-efficiency and high-accuracy system for rapid pathogenic microorganism identification that will initially include tests for…
Published on November 15, 2016
A team of scientists led by researchers at the National Institutes of Health (NIH) reviewed the growing body of research on how big data can impact infectious diseases and has published its analyses in a special issue of The Journal of Infectious Diseases. Big data derived from electronic health records,…
Published on July 1, 2015
You’re a physician working in West Africa for Doctors Without Borders, and a child has been brought into your clinic who is febrile and complaining of a headache, fatigue, and malaise. Given your locale and the current season, two of the most probable diagnoses would be either malaria or Ebola.…